General MM

What data are expected this year within the field of CAR T for multiple myeloma?

L: English

During the 2nd European CAR T Cell Meeting in Sitges, ES, the Multiple Myeloma Hub was delighted to speak to Mohamad Mohty, Saint-Antoine Hospital and Sorbonne University, Paris, FR. We asked: What data are expected this year within the field of CAR T for multiple myeloma?

Mohamad Mohty discusses CAR T-cell therapy in multiple myeloma, he explains that there is an unmet need for treatment, especially in the relapsed/refractory setting. He discusses clinical trials such as CARTITUDE, bb2121, and Legend trials, that evaluated response rates and outcomes in patients with multiple myeloma that were treated with CAR T and explains the results are encouraging.